Back to mobile site

Allergan (AGN) Tops Q4 EPS by 14c, Offers Q1 and FY Guidance, Approves $2B Buyback

January 29, 2019 7:04 AM EST Send to a Friend
(Updated - January 29, 2019 7:12 AM EST)Allergan (NYSE: AGN) reported Q4 EPS of $4.29, $0.14 better than the analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login